Tango Therapeutics Inc at Jefferies London Healthcare Conference Transcript
Hello, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. Thanks so much for joining us today in London, for the Jefferies Healthcare Conference. I'd like to welcome, Barbara Weber, the President, and CEO of Tango Therapeutics. A really interesting, targeted oncology company.
And without further ado, I'll pass it over to Barbara to tell you more about the company. And I think if there's a few minutes at the end, we'll do Q&A as well.
Great. Thank you, Maury, and thank you, everybody, for taking the time to come and hear our story this morning. Tango is a company that we started more than five years ago now, but actually which came from work that I've been doing, most of my adult life, working in cancer genetics and working on BRCA 1/2 and recognizing early on in that process.
Well, there were targeted agents that could inhibit activated oncogene that tumor suppressor genes like BRCA 1/2 among others were
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
